$TU YI HLDG(01701)$  With China opening up and travel reaching 75% pre-pandermic level, this travel stock has a lot of potential ahead and currently grossly undervalued. By next year, this stock will report multiple times above the current revenue and profits. The current covid-19 infection rising rate is expected. As more people became fully vaccinated and recovered, the infection rates will stabilized and trend downwards. This is part of relaxation of covid-19 lockdown as seen in many other countries.  Target price is above HKD1.20 similar to pre-covid days. Tourism and travel in China will eventually be back to normal as seen in other countries worldwide.